1. Home
  2. ACXP vs BNRG Comparison

ACXP vs BNRG Comparison

Compare ACXP & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • BNRG
  • Stock Information
  • Founded
  • ACXP 2017
  • BNRG 2012
  • Country
  • ACXP United States
  • BNRG Israel
  • Employees
  • ACXP N/A
  • BNRG N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • ACXP Health Care
  • BNRG
  • Exchange
  • ACXP Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • ACXP 6.8M
  • BNRG 6.2M
  • IPO Year
  • ACXP 2021
  • BNRG 2022
  • Fundamental
  • Price
  • ACXP $5.08
  • BNRG $1.52
  • Analyst Decision
  • ACXP Strong Buy
  • BNRG
  • Analyst Count
  • ACXP 3
  • BNRG 0
  • Target Price
  • ACXP $143.67
  • BNRG N/A
  • AVG Volume (30 Days)
  • ACXP 1.6M
  • BNRG 88.8K
  • Earning Date
  • ACXP 11-12-2025
  • BNRG 09-30-2025
  • Dividend Yield
  • ACXP N/A
  • BNRG N/A
  • EPS Growth
  • ACXP N/A
  • BNRG N/A
  • EPS
  • ACXP N/A
  • BNRG N/A
  • Revenue
  • ACXP N/A
  • BNRG $387,000.00
  • Revenue This Year
  • ACXP N/A
  • BNRG N/A
  • Revenue Next Year
  • ACXP N/A
  • BNRG N/A
  • P/E Ratio
  • ACXP N/A
  • BNRG N/A
  • Revenue Growth
  • ACXP N/A
  • BNRG 843.90
  • 52 Week Low
  • ACXP $3.80
  • BNRG $1.50
  • 52 Week High
  • ACXP $39.00
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 38.27
  • BNRG 36.25
  • Support Level
  • ACXP $6.24
  • BNRG $1.52
  • Resistance Level
  • ACXP $6.80
  • BNRG $1.75
  • Average True Range (ATR)
  • ACXP 0.52
  • BNRG 0.08
  • MACD
  • ACXP -0.31
  • BNRG -0.01
  • Stochastic Oscillator
  • ACXP 0.00
  • BNRG 0.57

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: